RPID Rapid Micro Biosystems, Inc.
Healthcare$2.05-0.97%ClosedMarket Cap: $92.9M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
4.57
P/S
2.70
EV/EBITDA
-2.21
DCF Value
$-16.50
FCF Yield
-39.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
12.4%
Operating Margin
-144.2%
Net Margin
-145.8%
ROE
-131.5%
ROA
-80.4%
ROIC
-111.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $8.0M | 4.6% | $-13.9M | $-14.3M | $— | — |
| Q4 null | $11.3M | -2.9% | $-12.2M | $-12.5M | $— | — |
| FY null | $33.6M | 22.7% | $-47.4M | $-47.1M | $— | — |
| Q3 null | $7.8M | 29.0% | $-11.4M | $-11.5M | $— | — |
| Q2 null | $7.3M | 26.8% | $-12.1M | $-11.9M | $— | — |
| Q1 null | $7.2M | 5.6% | $-11.7M | $-11.3M | $— | — |
| Q4 null | $8.2M | 11.9% | $-10.2M | $-9.7M | $— | — |
| FY null | $28.1M | -0.4% | $-49.9M | $-46.9M | $— | — |
| Q3 null | $7.6M | 8.2% | $-12.0M | $-11.3M | $— | — |
| Q2 null | $6.6M | -2.9% | $-13.4M | $-12.6M | $— | — |
| Q1 null | $5.6M | -27.1% | $-14.3M | $-13.3M | $— | — |
| Q4 2023 | $6.3M | -2.7% | $-12.2M | $-11.2M | $-0.26 | — |